Related Experiment Videos
[Second opinion as expert consultation--general practitioner as referral source].
1Abteilung für Allgemeinmedizin, Universität Ulm. hans-peter.zeitler@medizin.uni-ulm.de
MMW Fortschritte Der Medizin
|June 13, 2000
Summary
Family doctors are crucial for cancer patients seeking a second opinion, especially in palliative care. Their involvement ensures patients receive informed guidance, avoiding unnecessary distress and dashed hopes.
Area of Science:
- Oncology
- Primary Care Medicine
- Patient Advocacy
Context:
- The established trust between family doctors and patients is vital for discussing sensitive health matters like cancer.
- Patients often turn to their family doctor first when considering a second opinion, particularly during palliative care.
- Effective cancer care requires seamless communication and collaboration among all healthcare providers.
Purpose:
- To highlight the indispensable role of family doctors in facilitating informed second opinions for cancer patients.
- To emphasize the need for integrating family doctors into the multidisciplinary cancer care network.
- To underscore how family doctors can guide patients toward well-founded second opinions, preventing medical uncertainty and emotional distress.
Summary:
- Family doctors, due to their long-standing relationships and comprehensive understanding of patients' situations, are ideally positioned to assist with second opinions in cancer care.
- Their inclusion in the communication network of cancer patient care is essential for them to effectively guide patients.
- Informed family doctor involvement can prevent patients from undergoing a series of unproductive consultations and experiencing significant disappointment.
Impact:
- Enhances patient trust and shared decision-making in cancer treatment.
- Improves the efficiency and effectiveness of seeking second opinions.
- Reduces patient anxiety and emotional burden associated with cancer diagnosis and treatment planning.
- Strengthens the primary care physician's role in complex oncological care pathways.